Bradley M. Nagel - 04 Jun 2026 Form 4 Insider Report for Electromed, Inc. (ELMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Jun 2026, 19:39:19 UTC
Prior SEC filing
04 Sep 2025
Next SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joshua L. Colburn, Attorney-in-Fact

Key filing fact

Bradley M. Nagel filed Form 4 for Electromed, Inc. (ELMD) on 08 Jun 2026.

Key facts

  • This page summarizes Bradley M. Nagel's Form 4 filing for Electromed, Inc. (ELMD).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Jun 2026, 19:39.

Change

  • Previous filing in this sequence was filed on 04 Sep 2025.
  • Current net transaction value: -$428,936.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001954272 Primary reporting owner

Nagel Bradley M.

Relationship
Chief Financial Officer
Address
500 SIXTH AVENUE NW, NEW PRAGUE
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Signature date
08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELMD transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,334
Change %
+20%
Price
$10.25*
Shares after
26,172
Date
04 Jun 2026
Ownership
Direct
ELMD transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,267
Change %
+20%
Price
$10.71*
Shares after
31,439
Date
04 Jun 2026
Ownership
Direct
ELMD transaction

Common Stock

Sale

Transaction value
$422,219
Shares
-11,620
Change %
-37%
Price
$36.34
Shares after
19,819
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1
ELMD transaction

Common Stock

Sale

Transaction value
$6,718
Shares
-181
Change %
-0.91%
Price
$37.11
Shares after
19,638
Date
04 Jun 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELMD transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-4,334
Change %
-67%
Price
$0.000000*
Shares after
2,166
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,334
Exercise price
$10.25
Footnotes
F3
ELMD transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-5,267
Change %
-67%
Price
$0.000000*
Shares after
2,633
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,267
Exercise price
$10.71
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects the weighted average price of 11,620 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $36.04 to $37.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

Reflects the weighted average price of 181 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on June 4, 2026 with sale prices ranging from $37.055 to $37.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Scheduled to vest and become exercisable with respect to remaining shares on June 30, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .